The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected ...

British retailer the John Lewis Partnership said on Friday it remained on track to deliver "significantly higher" annual ...

Microsoft Corp. said Wednesday that its profit for the October-December quarter grew 10% from the same time last year as it ...

Putting money into growth stocks with a lot of potential upside can deliver life-changing returns. Typically, however, that ...

Meta Platforms reported strong Q4 earnings, driven by user growth and robust digital ad spending. Click here to find out why ...

Investors grow concerned that AI expenses and a looming price war in cloud services could blow up its profits.

Corcept Therapeutics' long-term goal is $3 billion revenue by 2029, driven by the new drug Relacorilant. Click here to read ...

Titan’s revenue from operations in Q3FY25 is estimated to grow 25% YoY, while its net profit is expected to remain flat due ...

This compares with the 22% profit increase on 12% sales growth that Novartis reported for 2024. Core operating profit for the fourth quarter grew to $4.86 billion from $3.82 billion for the same ...